omeprazole has been researched along with Acute Edematous Pancreatitis in 15 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present a rare side effect, acute pancreatitis, occurring in a patient who was treated with the proton pump inhibitor omeprazole." | 7.73 | Acute pancreatitis associated with omeprazole. ( Iskandar, SB; Roy, TM; Scruggs, J; Youssef, SS, 2005) |
| "To compare, during strong acid inhibition with omeprazole, the effect of 2 different doses of an enteric-coated pancreatic enzyme preparation on fecal fat excretion and abdominal symptoms in patients with exocrine insufficiency due to chronic pancreatitis (CP)." | 5.12 | Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency. ( Lamers, CB; Masclee, AA; Symersky, T; Vecht, J, 2006) |
| " MATERIAL OG METHODS: Fifteen healthy subjects and seven patients with chronic pancreatitis were entered in a randomised, double-blind, cross-over study of the exocrine pancreatic function after placebo or omeprazole 80 mg daily for three days." | 5.10 | [Does intake of gastric acid pump inhibitor affect the evaluation of the Lundh test?]. ( Damborg, F; Damborg, SB; Schaffalitzky de Muckadell, OB, 2002) |
| "gov and Cochrane Library from inception to June 30,2021 to retrieve relevant studies using the search strategy: ("Proton pump inhibitors" OR "PPI" OR "PPIs" OR "Omeprazole" OR "Tenatoprazole" OR "Pantoprazole" OR "acid suppression therapy" OR "acid suppression drugs") AND ("pancreatitis" OR "pancreatitides")." | 4.02 | Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis. ( Cheng, T; Gu, ZH; Han, TY; Liu, BF; Pan, P; Yu, H, 2021) |
| " We present a rare side effect, acute pancreatitis, occurring in a patient who was treated with the proton pump inhibitor omeprazole." | 3.73 | Acute pancreatitis associated with omeprazole. ( Iskandar, SB; Roy, TM; Scruggs, J; Youssef, SS, 2005) |
| "Chronic pancreatitis was alcohol-related in 23 patients, previous surgery was performed in 9, 16 had diabetes and all had steatorrhoea (fat balance > 10g/24h)." | 2.68 | Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. ( Buedts, K; Cremer, M; Delhaye, M; Gohimont, AC; Meuris, S, 1996) |
| "Acute pancreatitis is a pancreatic inflammation that recognises Salmonella typhi among its aetiological agents." | 1.34 | [Typhoid fever and acute pancreatitis: two cases]. ( Bertuccio, SN; Rombolà, F, 2007) |
| "Omeprazole was administered intraperitoneally, twice a day, for 3 days to the male rats in 0." | 1.31 | Temporary elevation of pancreatic lysosomal enzymes, as a result of the omeprazole-induced peripancreatic inflammation in male Wistar rats. ( Burdan, F; Burski, K; Maciejewski, R; Siezieniewska, Z; Wójtowicz, Z, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 12 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Collen, LV | 1 |
| Mitchell, PD | 1 |
| Fox, VL | 1 |
| Grover, AS | 1 |
| Cheng, T | 1 |
| Liu, BF | 1 |
| Han, TY | 1 |
| Gu, ZH | 1 |
| Pan, P | 1 |
| Yu, H | 1 |
| Iwańczak, B | 1 |
| Stawarski, A | 1 |
| Hutyra, T | 1 |
| Mowszet, K | 1 |
| Iwańczak, F | 1 |
| Wawro, J | 1 |
| Damborg, F | 1 |
| Damborg, SB | 1 |
| Schaffalitzky de Muckadell, OB | 1 |
| Sablin, OA | 1 |
| Ratnikov, VA | 1 |
| Butenko, EV | 1 |
| Pakhomova, IG | 1 |
| Starostin, BD | 1 |
| Kaur, S | 1 |
| Norkina, O | 1 |
| Ziemer, D | 1 |
| Samuelson, LC | 1 |
| De Lisle, RC | 1 |
| Osipenko, MF | 1 |
| Venzhina, IuIu | 1 |
| Youssef, SS | 1 |
| Iskandar, SB | 1 |
| Scruggs, J | 1 |
| Roy, TM | 1 |
| Vecht, J | 1 |
| Symersky, T | 1 |
| Lamers, CB | 1 |
| Masclee, AA | 1 |
| Rombolà, F | 1 |
| Bertuccio, SN | 1 |
| Lai, KC | 1 |
| Cheng, CH | 1 |
| Leung, PS | 1 |
| Delhaye, M | 1 |
| Meuris, S | 1 |
| Gohimont, AC | 1 |
| Buedts, K | 1 |
| Cremer, M | 1 |
| Burdan, F | 1 |
| Siezieniewska, Z | 1 |
| Maciejewski, R | 1 |
| Burski, K | 1 |
| Wójtowicz, Z | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Enzyme Substitution in Exocrine Pancreatic Insufficiency; Self Administration Against a Fixed Dose Regimen[NCT01430234] | Phase 4 | 10 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for omeprazole and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
[Does intake of gastric acid pump inhibitor affect the evaluation of the Lundh test?].
Topics: Adult; Amylases; Anti-Ulcer Agents; Chronic Disease; Cross-Over Studies; Double-Blind Method; Duoden | 2002 |
[Combination therapy of chronic pancreatitis (double-blind, placebo-controlled, pilot studies)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Chronic Disease; Double-Blind Method | 2003 |
Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency.
Topics: Adult; Aged; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Exocrine Panc | 2006 |
Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Topics: Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Exocrine Pancreatic Ins | 1996 |
11 other studies available for omeprazole and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Pancreatitis-Associated Medication Use in Hospitalized Pediatric and Young Adult Patients With Acute Pancreatitis.
Topics: Acute Disease; Child; Hospitalization; Humans; Omeprazole; Pancreatitis; Retrospective Studies; Youn | 2023 |
Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Humans; Meta-Analysis as Topic; Omeprazole; Pancreatitis; P | 2021 |
[Acute pancreatitis as a complication of diagnostic gastroduodenal endoscopy at 10 years old girl--case report].
Topics: Acute Disease; Child; Endoscopy, Gastrointestinal; Female; Humans; Omeprazole; Pancreatitis; Pancrea | 2008 |
[Clinical aspects of using pariet in treating chronic pancreatitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Chronic Disease; Enzyme Inhibitors; Humans; | 2002 |
Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas.
Topics: Acids; Amylases; Animals; Chimera; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regula | 2004 |
[Problems of excretory insufficiency of the pancreas].
Topics: Adolescent; Adult; Aged; Famotidine; Feces; Female; Histamine H2 Antagonists; Humans; Male; Middle A | 2004 |
Acute pancreatitis associated with omeprazole.
Topics: Aged, 80 and over; Anti-Ulcer Agents; Enzyme Inhibitors; Humans; Male; Omeprazole; Pancreatitis; Pro | 2005 |
[Typhoid fever and acute pancreatitis: two cases].
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Ceftriaxone; Female; | 2007 |
The ghrelin system in acinar cells: localization, expression, and regulation in the exocrine pancreas.
Topics: Achlorhydria; Acute Disease; Animals; Autocrine Communication; Ceruletide; Food Deprivation; Gastric | 2007 |
Temporary elevation of pancreatic lysosomal enzymes, as a result of the omeprazole-induced peripancreatic inflammation in male Wistar rats.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Lysosomes; Male; Omeprazole; Pancreas; Pancreatitis; Rats | 2000 |
From the Food and Drug Administration.
Topics: Antineoplastic Agents; Biological Products; Gastrinoma; Gastrointestinal Agents; Humans; Investigati | 2002 |